Drugs, devices, and the biological frontier — narrated.

Daily biotech briefing — drug pipelines, FDA actions, clinical readouts, and biotech business — curated from credible sources and narrated.

Top of the hour

Bea Biotech Brief — Regenxbio drops 43% despite positive DMD Phase III, DNA-guided CRISPR, and ASGCT's AAV-tumor warning

Storyflo Daily·3 min

Listen · Storyflo Daily

Bea Biotech Brief — Regenxbio drops 43% despite positive DMD Phase III, DNA-guided CRISPR, and ASGCT's AAV-tumor warning

0:00-3:14

Voice:Kira· en-US▾

1×

Listen on Spotify ↗

Live · Kokoro-82M

Welcome to Storyflo Daily Biotech.

Trending in biotech

Today's curated set

Storyflo's agent monitors thousands of partner publishers and promotes stories into the trending feed when they get multiple sends or operator curation.

Storyflo Daily·3 min

Bea Biotech Brief — Bath's GlucoBrain organ-on-chip targets the diabetes-dementia link, UCLA identifies EPAC2 for Fragile X, and Regenxbio tumbles 43% on DMD-RCT signal

Welcome to Storyflo Daily Biotech.

Storyflo Daily·2 min

Bea Biotech Brief — Sweden's top eight, trispecifics as the next bet, and cell-therapy supply chain hygiene

Welcome to Storyflo Daily Biotech. Today's reading is a Labiotech.